September / October 2021
Features
Who’s predisposed to anti-VEGF-induced IOI?
What clinical trials and postmarket data reveal about intraocular inflammation risk with brolucizumab.
Treat and extend: An international view
Three experts from Canada, Switzerland and Israel provide insights into the nuances of adherence, treatment intervals and emerging therapies.
Understanding the risks of systemic vascular disease
The retina is the canary in the coal mine for evaluating future systemic vascular disease in people with diabetes.
Making the retina workplace more ergonomically friendly
How a few modifications in the clinic and OR—and perhaps some yoga—can help overcome occupational aches and pains.
Departments
Clinical Trial Closeup
A potential stem-cell solution for GA
Trial shows safety of a biosynthetic patch inserted in a subretinal bleb in an outpatient procedure.
Coding Commentary
EO: If you do it, you should bill it
Extended ophthalmoscopy is a charge retina specialists commonly miss. Here’s how to bill for it.
Editor's Page
Imaging Forum
Not just pigments of your imagination
A case of idiopathic intrigue requiring investigation of an inflammatory cause.
News
Surgical Pearl Video
Passive PFO-SO exchange
A technique for actively injecting silicone oil while passively extruding peruorocarbon with a backush cannula.
Uveitis Forum
Using anti-VEGF agents in uveitis
A review of the available evidence and anecdotal reports supporting their use.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
